| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/02/1997 | EP0750633A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 01/02/1997 | EP0750604A1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
| 01/02/1997 | EP0750515A1 Low molecular weight hyaluronic acid with peptide or protein |
| 01/02/1997 | EP0750513A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 01/02/1997 | EP0750495A1 Delivery systems for hydrophobic drugs |
| 01/02/1997 | EP0750494A1 Hydrophobic drug delivery systems |
| 01/02/1997 | EP0750493A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
| 01/02/1997 | EP0619743B1 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 01/02/1997 | DE19625027A1 Medicament prepn. for prodn. of propellant gas-free aerosol |
| 01/02/1997 | DE19522693A1 Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung A composition for preparing a finely dispersed systems and methods for their preparation |
| 01/01/1997 | CN1139423A Method for colouring piece of rock by laser rays |
| 01/01/1997 | CN1139386A Microcapsules, method of making and their use |
| 01/01/1997 | CN1139384A Use of mometasone furoate for treating airway passage and lung diseases |
| 01/01/1997 | CN1139382A Modified-release metronidazole compositions and methods for making and using same |
| 01/01/1997 | CN1139380A Controlled release preparation |
| 12/31/1996 | US5589591 Endotoxin-free polysaccharides |
| 12/31/1996 | US5589516 Liquid preparation of antithrombin-III and stabilizing method therefor |
| 12/31/1996 | US5589509 Enhancing effect of administered tumor cell-locating porphyrins in light irradiation to destroy tumor cells |
| 12/31/1996 | US5589508 Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases |
| 12/31/1996 | US5589505 Method of treating wrinkles using quinic acid or quinolactone |
| 12/31/1996 | US5589463 Oral delivery of biologically active substances bound to vitamin B12 |
| 12/31/1996 | US5589452 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 12/31/1996 | US5589198 Treatment of iodine deficiency diseases |
| 12/31/1996 | US5589195 Film-forming proteinaceous emulsion |
| 12/31/1996 | US5589192 Gel pharmaceutical formulation for local anesthesia |
| 12/31/1996 | US5589191 Slow-release sodium valproate tablets |
| 12/31/1996 | US5589180 Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine |
| 12/31/1996 | US5589179 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it |
| 12/31/1996 | US5589178 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof |
| 12/31/1996 | US5589169 Topical application of tissue plasminogen activator |
| 12/31/1996 | US5589167 Excipient stabilization of polypeptides treated with organic solvents |
| 12/31/1996 | US5589159 Treating teeth with oral composition comprising hectorite clay |
| 12/31/1996 | CA2180206A1 Freeze-dried preparation for pharmaceutical use |
| 12/31/1996 | CA1338819C Transdermal estradiol delivery system |
| 12/31/1996 | CA1338818C Immunotoxins |
| 12/27/1996 | WO1996041873A1 Dry powder formulations of polynucleotide complexes |
| 12/27/1996 | WO1996041818A1 Chitin hydrogels, methods of their production and use |
| 12/27/1996 | WO1996041817A1 Collagen peptide fraction and its uses |
| 12/27/1996 | WO1996041813A2 Functionalized polymers for site-specific attachment |
| 12/27/1996 | WO1996041646A2 Pharmaceutical compositions containing lornoxicam and cyclodextrin |
| 12/27/1996 | WO1996041642A1 Stable freeze-dried composition containing tpo |
| 12/27/1996 | WO1996041618A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 12/27/1996 | WO1996041616A1 Formulations and methods for providing prolonged local anesthesia |
| 12/27/1996 | WO1996041608A2 Pyrularia thionin containing immunotoxins and immunotoxin-like conjugates |
| 12/27/1996 | WO1996041606A2 Improved pharmaceutical compositions for gene therapy |
| 12/27/1996 | WO1996025956A3 Individual medicament dosing conjugate |
| 12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
| 12/27/1996 | EP0749747A1 Composition contenant a dispersion of polymer particles in a non aqueous medium |
| 12/27/1996 | EP0749447A1 Water-soluble dextran fatty acid esters and their use as solubilisers |
| 12/27/1996 | EP0749446A1 Highly reactive esters of carboxy polysaccharides and novel carboxy polysaccharides derived therefrom |
| 12/27/1996 | EP0749440A1 Method of isolating and purifying a biomacromolecule |
| 12/27/1996 | EP0749439A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof |
| 12/27/1996 | EP0749325A1 Bispecific molecules having clinical utilities |
| 12/27/1996 | EP0749324A1 Veterinary formulation |
| 12/27/1996 | EP0749314A1 Method for treating and inhibiting gastric and duodenal ulcers |
| 12/27/1996 | EP0749308A1 Film coated tablet of paracetamol and domperidone |
| 12/27/1996 | EP0749304A1 Slow-release tablet containing diclofenac-na |
| 12/27/1996 | EP0749300A1 Pharmaceutical excipient having improved compressibility |
| 12/27/1996 | EP0749277A1 Coprocessed galactomannan - glucomannan |
| 12/27/1996 | EP0633784B1 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A |
| 12/27/1996 | CA2224253A1 Chitin hydrogels, methods of their production and use |
| 12/27/1996 | CA2224156A1 Dry powder formulations of polynucleotide complexes |
| 12/27/1996 | CA2223749A1 Stable tpo-containing lyophilized compositions |
| 12/27/1996 | CA2223568A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 12/27/1996 | CA2204726A1 Functionalized polymers for site-specific attachment |
| 12/25/1996 | CN1138828A Prepn. of hollow microcapsules |
| 12/25/1996 | CN1138827A Process for solubilizing difficultly soluble pharmaceutical actives |
| 12/24/1996 | US5587478 Sapphyrin multimers |
| 12/24/1996 | US5587469 Oligonucleotides containing N-2 substituted purines |
| 12/24/1996 | US5587459 Linked to a ligand targeting a cell surface receptor; for treating cancers and autoimmune diseases |
| 12/24/1996 | US5587442 Antiinflammatory agents |
| 12/24/1996 | US5587371 Effective for treating hypoxic areas of solid neoplasms |
| 12/24/1996 | US5587368 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury |
| 12/24/1996 | US5587179 Pharmaceutical formulation in the form of an effervescent and/or disintegrating tablet or of instant granulate, and process for their preparation |
| 12/24/1996 | US5587161 Prodrugs for antibody directed enzyme prodrug therapy |
| 12/24/1996 | US5587144 Diazine chelating agents for diagnostic imaging |
| 12/24/1996 | US5587143 Adsorbed on surface |
| 12/19/1996 | WO1996041236A1 Therapeutic microdevices and methods of making and using same |
| 12/19/1996 | WO1996041144A2 Polyoxyhydrocarbyl marker products and methods for fluorescence assays |
| 12/19/1996 | WO1996040963A1 Cationic lipid:dna complexes for gene targeting |
| 12/19/1996 | WO1996040962A1 Cationic lipid:dna complexes for gene targeting |
| 12/19/1996 | WO1996040958A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
| 12/19/1996 | WO1996040912A1 Ob protein compositions and method |
| 12/19/1996 | WO1996040890A1 Non-naturally occurring targeted lipolytic compounds: synthesis, demonstration of potency, and practical and therapeutic applications |
| 12/19/1996 | WO1996040829A1 Crosslinkable polypeptide compositions |
| 12/19/1996 | WO1996040795A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 12/19/1996 | WO1996040792A1 Modification of polypeptides |
| 12/19/1996 | WO1996040791A1 Modification of polypeptides |
| 12/19/1996 | WO1996040784A2 Method of solubilizing, purifying, and refolding protein |
| 12/19/1996 | WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia |
| 12/19/1996 | WO1996040761A1 Modified avidin and streptavidin and methods of use thereof |
| 12/19/1996 | WO1996040725A1 Phosphonic acid-based cationic lipids |
| 12/19/1996 | WO1996040664A2 Preparation of immunogens and other conjugates of drugs |
| 12/19/1996 | WO1996040662A2 Aminooxy-containing linker compounds and their application in conjugates |
| 12/19/1996 | WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS |
| 12/19/1996 | WO1996040355A1 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 12/19/1996 | WO1996040285A1 Novel targeted compositions for diagnostic and therapeutic use |
| 12/19/1996 | WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 12/19/1996 | WO1996040269A1 INCREASING rAAV TITER |
| 12/19/1996 | WO1996040265A1 Stabilization of polynucleotide complexes |